Saad Ullah
Hims & Hers Health (HIMS) has quietly become one of the more striking growth stories in telehealth. Over the past five years, the company scaled from a niche wellness platform into a multi-billion-dollar business, and the numbers behind that transformation are worth a closer look.
From $171M to $2.35B: HIMS Posts 1,272% Revenue Growth
Financial data shows HIMS trailing twelve-month revenue climbed from roughly $171 million in early 2021 to approximately $2.35 billion by 2025. That works out to a total increase of around 1,272%, with a compound annual growth rate near 73.5%.
The climb was steady rather than sudden: revenue passed through milestones of $320.9 million, $526.9 million, and $710.7 million before crossing the $1 billion threshold and accelerating further. The growth unfolded in parallel with the removal of earlier legal risks that had weighed on the stock, according to HIMS Revenue Surges 1300% to $599M Over Five Years.
P/S Ratio Down 74% Even as Sales Scale Toward $2.35B
While revenue expanded, valuation metrics moved in the opposite direction. The price-to-sales ratio declined roughly 73.8% over the same period, reflecting a compound annual contraction near 19.5%. In practical terms, the market is now pricing each dollar of HIMS revenue far more conservatively than it did when the company was smaller. That kind of compression is not unique to HIMS. Across high-growth tech and telehealth, equity markets broadly reassessed how much premium to assign businesses still in growth mode as macroeconomic conditions shifted and profitability expectations tightened. Recent coverage tracked in HIMS Stock: Short Squeeze Speculation Fuels Rally as $2.35B Revenue Shows 40% Growth reflects how that tension continues to shape investor sentiment.
The setup is unusual by most measures. A company posting 73.5% annualized revenue growth while its valuation multiple shrinks by nearly three-quarters is not something that appears often in market data. Whether that gap closes through price appreciation or through a moderation in growth expectations remains the open question, and one that analysts tracking the stock continue to debate. For a longer view on where the stock has traded relative to those fundamentals, HIMS Stock Drops 75% From $60 Peak, but Elliott Wave Still Eyes $127 Target offers useful context on the price trajectory.
Saad Ullah
